Latest Breaking News On - Treprostinil injection - Page 12 : comparemela.com

Provided by GlobeNewswire May 24, 2021 8:05 PM UTC MORRISVILLE, N.C., May 24, 2021 (GLOBE NEWSWIRE) Liquidia Corporation (NASDAQ: LQDA) (“Liquidia” or the “Company”) today announced that Sandoz Treprostinil Injection, a generic form of Remodulin®, is now also available for subcutaneous (“SC”) administration to treat patients diagnosed with pulmonary arterial hypertension (“PAH”). Sandoz Treprostinil Injection was the first fully-substitutable AP rated generic version of Remodulin. Both options for intravenous and SC administration of Sandoz generic Treprostinil Injection are now available at the same specialty pharmacy that dispenses the brand name medicine. On May 21, 2021, Liquidia PAH’s manufacturing partner, Chengdu Shifeng Medical Technologies LTD (“Chengdu”) began selling the RG 3ml Medication Cartridge, which may be used to supply medications to PAH patients. Liquidia had previously announced the FDA’s clearance of Chengdu�

United statesScott moomawKeren haruviJason adairLiquidia technologies incUnited therapeutics corporationSandoz incUs district courtLiquidia corporationCorporate developmentChengdu shifeng medical technologiesSmiths medical asd incSandoz treprostinil injectionTreprostinil injectionMedication cartridgeSmiths medical